Meitheal Pharmaceuticals has Enoxaparin Sodium Injection, USP Now Available

Share Facebook icon Twitter icon Linkedin icon
October 03, 2022

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Enoxaparin Sodium Injection, USP 300mg/3mL Multi-Dose Vial.

Meitheal will offer Enoxaparin Sodium Injection, USP in a carton of 1 vial.

ABOUT ENOXAPARIN SODIUM INJECTION

Enoxaparin Sodium Injection is a low molecular weight heparin indicated for prophylaxis and treatment of deep vein thrombosis and myocardial infarction. For full prescribing information, please click on the following link.


Learn more about Enoxaparin Sodium Injection, USP

New Launches
Ganirelix Acetate Injection Now Available

Ganirelix Acetate Injection Now Available

 Furosemide Injection, USP Now Available

Furosemide Injection, USP Now Available
This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices